tetano
Editor, Senior Moderator
Clin Infect Dis
. 2024 Feb 27:ciae105.
doi: 10.1093/cid/ciae105. Online ahead of print. Combined protection of vaccination and nirmatrelvir-ritonavir against hospitalization in adults with COVID-19
Melisa M Shah[SUP] 1 [/SUP], Brendan Joyce[SUP] 2 [/SUP], Ian D Plumb[SUP] 1 [/SUP], Sam Sahakian[SUP] 2 [/SUP], Leora R Feldstein[SUP] 1 [/SUP], Eric Barkley[SUP] 2 [/SUP], Mason Paccione[SUP] 2 [/SUP], Joseph Deckert[SUP] 2 [/SUP], Danessa Sandmann[SUP] 2 [/SUP], Melissa Briggs Hagen[SUP] 1 [/SUP], Jacqueline L Gerhart[SUP] 2 [/SUP]
Affiliations
Among U.S. adults at risk for severe COVID-19 in Epic Cosmos, the lowest rate of hospitalization was among those receiving three or more mRNA vaccine doses and nirmatrelvir-ritonavir (aHR 0.22, 95%CI: 0.19-0.24). Adults who are at high-risk of severe COVID-19 disease, including vaccinated persons, should be considered for antiviral treatment.
Keywords: SARS-CoV-2; covid-19; nirmatrelvir-ritonavir; vaccination.
. 2024 Feb 27:ciae105.
doi: 10.1093/cid/ciae105. Online ahead of print. Combined protection of vaccination and nirmatrelvir-ritonavir against hospitalization in adults with COVID-19
Melisa M Shah[SUP] 1 [/SUP], Brendan Joyce[SUP] 2 [/SUP], Ian D Plumb[SUP] 1 [/SUP], Sam Sahakian[SUP] 2 [/SUP], Leora R Feldstein[SUP] 1 [/SUP], Eric Barkley[SUP] 2 [/SUP], Mason Paccione[SUP] 2 [/SUP], Joseph Deckert[SUP] 2 [/SUP], Danessa Sandmann[SUP] 2 [/SUP], Melissa Briggs Hagen[SUP] 1 [/SUP], Jacqueline L Gerhart[SUP] 2 [/SUP]
Affiliations
- PMID: 38411622
- DOI: 10.1093/cid/ciae105
Among U.S. adults at risk for severe COVID-19 in Epic Cosmos, the lowest rate of hospitalization was among those receiving three or more mRNA vaccine doses and nirmatrelvir-ritonavir (aHR 0.22, 95%CI: 0.19-0.24). Adults who are at high-risk of severe COVID-19 disease, including vaccinated persons, should be considered for antiviral treatment.
Keywords: SARS-CoV-2; covid-19; nirmatrelvir-ritonavir; vaccination.